LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China · Delayed Price · Currency is CNY 13.72
-0.11 (-0.80%)
May 8, 2026, 3:00 PM CST
SHA:603883 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 553.67 | 381.85 | 519.06 | 929.02 | 784.96 | 669.24 |
Depreciation & Amortization | 1,439 | 1,344 | 1,473 | 1,334 | 1,195 | 1,100 |
Other Amortization | 179.95 | 279.14 | 184.68 | 133.58 | 132.6 | 116.15 |
Loss (Gain) From Sale of Assets | 3.54 | 3.54 | 4.53 | -5.51 | -1.44 | -4.66 |
Asset Writedown & Restructuring Costs | 251.36 | 238.6 | 107.54 | - | - | - |
Loss (Gain) From Sale of Investments | -0.9 | -0.9 | -2.73 | -64.66 | -27.23 | -33.94 |
Provision & Write-off of Bad Debts | - | 16.75 | 1.09 | 10.59 | 7.18 | 5.65 |
Other Operating Activities | 189.9 | 299.18 | 354.58 | 405.87 | 427.38 | 313.98 |
Change in Accounts Receivable | 469.25 | 469.25 | -633.16 | 39.97 | -804.55 | -365.08 |
Change in Inventory | -87.25 | -87.25 | 576.06 | -202.63 | -974.55 | -226.86 |
Change in Accounts Payable | 218.15 | 218.15 | -526.47 | 150.8 | 1,562 | 721.6 |
Operating Cash Flow | 3,197 | 3,143 | 2,026 | 2,730 | 2,314 | 2,298 |
Operating Cash Flow Growth | 32.45% | 55.08% | -25.77% | 17.95% | 0.70% | 58.78% |
Capital Expenditures | -233.81 | -253.44 | -507.5 | -620.87 | -308.44 | -478.61 |
Sale of Property, Plant & Equipment | 2.29 | 8.25 | 8.24 | 7.48 | 11.58 | 19.53 |
Cash Acquisitions | -3 | -3.2 | -134.83 | -529.42 | -1,505 | -1,332 |
Divestitures | 7.15 | - | 25.94 | 14.12 | 8.86 | 60.04 |
Investment in Securities | 9.26 | 8.72 | -19.72 | 359.88 | 35.95 | -272.34 |
Other Investing Activities | 3.67 | 3.01 | - | 7.54 | 300.62 | 1.06 |
Investing Cash Flow | -214.44 | -236.66 | -627.88 | -761.26 | -1,457 | -2,002 |
Long-Term Debt Issued | - | 1,904 | 3,361 | 1,496 | 1,839 | 3,632 |
Total Debt Issued | 1,999 | 1,904 | 3,361 | 1,496 | 1,839 | 3,632 |
Short-Term Debt Repaid | - | - | - | - | -11.81 | -1.73 |
Long-Term Debt Repaid | - | -3,900 | -3,728 | -2,984 | -3,119 | -3,418 |
Total Debt Repaid | -2,460 | -3,900 | -3,728 | -2,984 | -3,131 | -3,420 |
Net Debt Issued (Repaid) | -461.46 | -1,996 | -367.49 | -1,488 | -1,292 | 211.88 |
Issuance of Common Stock | - | - | - | 6.3 | 1,774 | - |
Repurchase of Common Stock | - | -16.47 | -3.86 | -5.98 | -14.59 | -1.27 |
Common Dividends Paid | -223.16 | -224.62 | -714 | -374.71 | -302.16 | -168.23 |
Other Financing Activities | -1,686 | -511.76 | -262.99 | -565.93 | -307.88 | -455.59 |
Financing Cash Flow | -2,370 | -2,749 | -1,348 | -2,428 | -142.62 | -413.21 |
Foreign Exchange Rate Adjustments | - | - | - | -0.55 | 1.7 | -0.66 |
Net Cash Flow | 612.04 | 157.11 | 50.23 | -459.8 | 716.74 | -117.72 |
Free Cash Flow | 2,963 | 2,889 | 1,519 | 2,109 | 2,006 | 1,820 |
Free Cash Flow Growth | 56.08% | 90.21% | -27.98% | 5.14% | 10.23% | 72.78% |
Free Cash Flow Margin | 13.30% | 12.99% | 6.79% | 9.40% | 9.94% | 11.59% |
Free Cash Flow Per Share | 3.89 | 3.78 | 1.99 | 2.79 | 2.67 | 2.57 |
Cash Income Tax Paid | 913.2 | 895.13 | 976.07 | 911.78 | 655.76 | 542.13 |
Levered Free Cash Flow | 2,355 | 2,369 | 1,416 | 1,663 | 2,207 | 1,671 |
Unlevered Free Cash Flow | 2,355 | 2,451 | 1,527 | 1,779 | 2,352 | 1,791 |
Change in Working Capital | 580.93 | 580.93 | -615.3 | -12.8 | -203.9 | 132.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.